pulmicort and Small-Cell-Lung-Carcinoma

In the present study, we examined the effect of bexarotene (Targretin) and budesonide in the chemoprevention of small cell lung carcinoma using a lung-specific knockout model of Rb1 and p53. Upon treatment with bexarotene, tumor incidence, number, and load were significantly reduced (P < 0.05). Budesonide treatment trended to inhibition, but the effect was not statistically significant (P > 0.05). Immunohistochemical staining indicated that bexarotene treatment decreased cell proliferation and increased apoptosis in tumors. The Rb1/p53 gene-targeted mouse seems to be a valuable model for chemopreventive studies on human small cell lung cancer. Our results indicate that the retinoid X receptor agonist bexarotene may be a potent chemopreventive agent in this cancer type.

Topics: Adenoviridae; Animals; Anti-Inflammatory Agents; Anticarcinogenic Agents; Apoptosis; Bexarotene; Budesonide; Cell Proliferation; Disease Models, Animal; Female; Genetic Engineering; Immunoenzyme Techniques; In Situ Nick-End Labeling; Integrases; Lung Neoplasms; Male; Mice; Mice, Inbred A; Retinoblastoma Protein; Small Cell Lung Carcinoma; Tetrahydronaphthalenes; Tumor Suppressor Protein p53